Published in Am J Transplant on November 01, 2004
West Nile virus: review of the literature. JAMA (2013) 2.79
Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis (2012) 1.45
Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev (2008) 1.27
Progress on the development of therapeutics against West Nile virus. Antiviral Res (2009) 1.26
West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22
Clinical manifestations and outcomes of West Nile virus infection. Viruses (2014) 1.05
Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant (2009) 1.01
Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. PLoS One (2011) 0.98
Genetic variants and susceptibility to neurological complications following West Nile virus infection. J Infect Dis (2011) 0.92
Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS One (2014) 0.82
West Nile Virus Infection in the Immunocompromised Patient. Curr Infect Dis Rep (2013) 0.79
Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog (2016) 0.78
Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters. Am J Trop Med Hyg (2008) 0.77
Fatal West Nile Virus Encephalitis in a Heart Transplant Recipient. J Clin Microbiol (2015) 0.75
West Nile virus. Update for family physicians. Can Fam Physician (2005) 0.75
Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection. PLoS One (2016) 0.75
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation (2010) 4.00
Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology (2005) 3.14
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03
Evaluation of diagnostic tests: dengue. Nat Rev Microbiol (2010) 2.91
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med (2007) 2.64
The emergence of Lyme disease in Canada. CMAJ (2009) 2.47
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation (2013) 2.43
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol (2007) 2.35
Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis (2009) 2.26
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation (2004) 2.11
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis (2010) 1.98
RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med (2010) 1.94
Sequence analysis of the msp4 gene of Anaplasma phagocytophilum strains. J Clin Microbiol (2005) 1.84
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Rapid antigen-capture assay to detect West Nile virus in dead corvids. Emerg Infect Dis (2003) 1.70
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis (2009) 1.64
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest (2007) 1.57
An outbreak of West Nile virus-associated disease in domestic geese (Anser anser domesticus) upon initial introduction to a geographic region, with evidence of bird to bird transmission. Can Vet J (2004) 1.55
Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol (2009) 1.50
Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol (2008) 1.49
Detection of polyoma and corona viruses in bats of Canada. J Gen Virol (2009) 1.49
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant (2005) 1.45
West Nile virus surveillance and diagnostics: A Canadian perspective. Can J Infect Dis (2003) 1.44
Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol (2005) 1.43
Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients. Retina (2006) 1.42
Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One (2010) 1.38
Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis (2002) 1.37
Syndromic surveillance of gastrointestinal illness using pharmacy over-the-counter sales. A retrospective study of waterborne outbreaks in Saskatchewan and Ontario. Can J Public Health (2004) 1.35
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation (2010) 1.35
A GIS-driven integrated real-time surveillance pilot system for national West Nile virus dead bird surveillance in Canada. Int J Health Geogr (2006) 1.35
Susceptibility of pigs and chickens to SARS coronavirus. Emerg Infect Dis (2004) 1.35
Comparison of assays for the detection of West Nile virus antibodies in chicken serum. Can J Vet Res (2003) 1.33
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis (2012) 1.25
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14
Identification of dengue virus in respiratory specimens from a patient who had recently traveled from a region where dengue virus infection is endemic. J Clin Microbiol (2007) 1.10
State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician. Clin Infect Dis (2012) 1.10
Emerging and re-emerging infectious diseases. Med Microbiol Immunol (2002) 1.09
Serologic diagnosis of West Nile virus infection. Expert Rev Mol Diagn (2003) 1.09
Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation (2011) 1.07
Design of oligonucleotide arrays to detect point mutations: molecular typing of antibiotic resistant strains of Neisseria gonorrhoeae and hantavirus infected deer mice. Mol Cell Probes (2003) 1.06
Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation (2005) 1.05
A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis (2005) 1.05
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther (2009) 1.05
Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02
Distribution and phylogenetic comparisons of a novel mosquito flavivirus sequence present in Culex tarsalis Mosquitoes from western Canada with viruses isolated in California and Colorado. Am J Trop Med Hyg (2011) 1.01
Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation (2012) 1.00
A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis (2007) 1.00
Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection. BMC Immunol (2011) 0.99
Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. J Virol Methods (2004) 0.99
Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis (2003) 0.98
Immune markers associated with host susceptibility to infection with West Nile virus. Viral Immunol (2014) 0.98
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98
Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol (2005) 0.98
Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol (2002) 0.97
A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97
An international survey of cytomegalovirus management practices in lung transplantation. Transplantation (2010) 0.97
Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J Clin Microbiol (2008) 0.97
Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics. Clin Vaccine Immunol (2011) 0.97
Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients. Transplantation (2004) 0.95
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis (2008) 0.95
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis (2010) 0.94
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother (2007) 0.94
West Nile Virus infection in humans and horses, Cuba. Emerg Infect Dis (2006) 0.94
Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis (2005) 0.93
Graphium basitruncatum fungemia in a patient with acute leukemia. J Clin Microbiol (2007) 0.93
Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation (2003) 0.93
Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Kidney Dis (2010) 0.93
Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect Dis (2013) 0.92
Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients. Transplantation (2005) 0.92
Zoonotic infections in native communities of James Bay, Canada. Vector Borne Zoonotic Dis (2012) 0.92
Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation (2008) 0.92
Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients. Transplantation (2011) 0.91
Effects of porcine reproductive and respiratory syndrome vaccination in breeding-age animals. Prev Vet Med (2004) 0.91
A preliminary study of the patterns of Sin Nombre viral infection and shedding in naturally infected deer mice (Peromyscus maniculatus). Vector Borne Zoonotic Dis (2005) 0.91
Polyomavirus infection and acute vascular rejection in a kidney allograft: coincidence or mimicry? Am J Transplant (2003) 0.91
Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health (2006) 0.90
A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients. Clin Infect Dis (2008) 0.90
Evolutional and geographical relationships of Bartonella grahamii isolates from wild rodents by multi-locus sequencing analysis. Microb Ecol (2009) 0.90
Seroprevalence of 10 zoonotic infections in 2 Canadian Cree communities. Diagn Microbiol Infect Dis (2011) 0.89
A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant (2011) 0.89
Vertical transmission of Babesia microti, United States. Emerg Infect Dis (2012) 0.88
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. Transplantation (2013) 0.88
Ross River virus disease reemergence, Fiji, 2003-2004. Emerg Infect Dis (2005) 0.87
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant (2011) 0.87
Roles of host species, geographic separation, and isolation in the seroprevalence of Jamestown Canyon and snowshoe hare viruses in Newfoundland. Appl Environ Microbiol (2012) 0.86
Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay. J Vet Diagn Invest (2006) 0.86
The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation (2002) 0.86
Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California. Vet Res (2007) 0.86
Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test. Clin Vaccine Immunol (2007) 0.86